Leading science, pioneering therapies
CRM Publications

The developmental dismantling of pluripotency is reversed by ectopic Oct4 expression.

TitleThe developmental dismantling of pluripotency is reversed by ectopic Oct4 expression.
Publication TypeJournal Article
Year of Publication2012
AuthorsOsorno R, Tsakiridis A, Wong F, Cambray N, Economou C, Wilkie R, Blin G, Scotting PJ, Chambers I, Wilson V
JournalDevelopment
Volume139
Issue13
Pagination2288-98
Date Published2012 Jul
ISSN1477-9129
KeywordsAnimals, Cells, Cultured, Chromatin, Embryonic Development, Gene Expression Regulation, Developmental, Homeodomain Proteins, Male, Mice, Octamer Transcription Factor-3, Pluripotent Stem Cells
Abstract

The transcription factors Nanog and Oct4 regulate pluripotency in the pre-implantation epiblast and in derivative embryonic stem cells. During post-implantation development, the precise timing and mechanism of the loss of pluripotency is unknown. Here, we show that in the mouse, pluripotency is extinguished at the onset of somitogenesis, coincident with reduced expression and chromatin accessibility of Oct4 and Nanog regulatory regions. Prior to somitogenesis expression of both Nanog and Oct4 is regionalized. We show that pluripotency tracks the in vivo level of Oct4 and not Nanog by assessing the ability to reactivate or maintain Nanog expression in cell culture. Enforced Oct4 expression in somitogenesis-stage tissue provokes rapid reopening of Oct4 and Nanog chromatin, Nanog re-expression and resuscitates moribund pluripotency. Our data suggest that decreasing Oct4 expression is converted to a sudden drop in competence to maintain pluripotency gene regulatory network activity that is subsequently stabilized by epigenetic locks.

DOI10.1242/dev.078071
Alternate JournalDevelopment
PubMed ID22669820
PubMed Central IDPMC3367440
Grant ListG0802097 / / Medical Research Council / United Kingdom
G080297 / / Medical Research Council / United Kingdom
G0901533 / / Medical Research Council / United Kingdom
G091533 / / Medical Research Council / United Kingdom
WT073607/Z/03/Z / / Wellcome Trust / United Kingdom